Roman David 4
4 · Acutus Medical, Inc. · Filed Aug 1, 2022
Insider Transaction Report
Form 4
Roman David
SVP & Chief Financial Officer
Transactions
- Award
Employee Stock Options (Right to Buy)
2022-07-25+77,335→ 127,335 totalExercise: $1.34Exp: 2031-04-01→ Common Stock (77,335 underlying) - Award
Employee Stock Options (Right to Buy)
2022-07-25+50,000→ 127,335 totalExercise: $1.34Exp: 2032-02-01→ Common Stock (50,000 underlying) - Disposition to Issuer
Employee Stock Options (Right to Buy)
2022-07-25−77,335→ 50,000 totalExercise: $13.66Exp: 2031-04-01→ Common Stock (77,335 underlying) - Award
Common Stock
2022-08-01+75,000→ 258,355 total - Disposition to Issuer
Employee Stock Options (Right to Buy)
2022-07-25−50,000→ 77,335 totalExercise: $2.41Exp: 2032-02-01→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock units that vest in four equal installments on each of the first four anniversaries of the vesting commencement date, subject to continued service through each such vesting date.
- [F2]The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on April 1, 2021, with 1/4 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 36 equal monthly installments.
- [F3]The two reported transactions involved an amendment of an outstanding option reducing the exercise price of the option. The option was originally granted on February 1, 2022, with 1/2 vesting on the first anniversary of the vesting commencement date, and the remainder vesting in 12 equal monthly installments.